BRIEF-Bionano Reports Fourth Quarter And Full-Year 2023 Results

Reuters03-06

March 5 (Reuters) - Bionano Genomics Inc :

* BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES REVENUE OUTLOOK FOR 2024

* BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH COMPLETION OF INITIATIVE ANNOUNCED TODAY, WE AIM TO HAVE REDUCED HEADCOUNT BY APPROXIMATELY 200 PEOPLE

* BIONANO GENOMICS INC: REDUCED ANNUALIZED OPERATING EXPENSES BY ABOUT $65.0 TO $75.0 MILLION

* BIONANO GENOMICS INC: WITH 2024 COST SAVINGS INITIATIVE, WILL BE REDUCING ANNUALIZED OPERATING EXPENSE BY ANOTHER ESTIMATED $35.0 TO $40.0 MILLION

* BIONANO: INITIATIVE INCLUDES POTENTIAL REDUCTION IN HEADCOUNT BY AN ADDITIONAL 110 TO 125 EMPLOYEES

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2417420605?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-06 05:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2417420605","market":"us","top_or_hot":-1,"title":"BRIEF-Bionano Reports Fourth Quarter And Full-Year 2023 Results","media":"Reuters","content":"<html><body><p>March 5 (Reuters) - <a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a> Inc   :</p><p>   * BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES REVENUE OUTLOOK FOR 2024</p><p>   * BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH COMPLETION OF INITIATIVE ANNOUNCED TODAY, WE AIM TO HAVE REDUCED HEADCOUNT BY APPROXIMATELY 200 PEOPLE</p><p>   * BIONANO GENOMICS INC: REDUCED ANNUALIZED OPERATING EXPENSES BY ABOUT $65.0 TO $75.0 MILLION</p><p>   * BIONANO GENOMICS INC:  WITH 2024 COST SAVINGS INITIATIVE, WILL BE REDUCING ANNUALIZED OPERATING EXPENSE BY ANOTHER ESTIMATED $35.0 TO $40.0 MILLION</p><p>   * BIONANO: INITIATIVE INCLUDES POTENTIAL REDUCTION IN HEADCOUNT BY AN ADDITIONAL 110 TO 125 EMPLOYEES</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bionano Reports Fourth Quarter And Full-Year 2023 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bionano Reports Fourth Quarter And Full-Year 2023 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-06 05:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 5 (Reuters) - Bionano Genomics Inc   :   * BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES REVENUE OUTLOOK FOR 2024   * BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4575","symbol_name":"芯片概念","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2417420605","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2417420605","pubTimestamp":1709674513,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 5  - Bionano Genomics Inc   :   * BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES REVENUE OUTLOOK FOR 2024   * BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH COMPLETION OF INITIATIVE ANNOUNCED TODAY, WE AIM TO HAVE REDUCED HEADCOUNT BY APPROXIMATELY 200 PEOPLE   * BIONANO GENOMICS INC: REDUCED ANNUALIZED OPERATING EXPENSES BY ABOUT $65.0 TO $75.0 MILLION   * BIONANO GENOMICS INC:  WITH 2024 COST SAVINGS INITIATIVE, WILL BE REDUCING ANNUALIZED OPERATING EXPENSE BY ANOTHER ESTIMATED $35.0 TO $40.0 MILLION   * BIONANO: INITIATIVE INCLUDES POTENTIAL REDUCTION IN HEADCOUNT BY AN ADDITIONAL 110 TO 125 EMPLOYEESSource text for Eikon:    Further company coverage:","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4575":"芯片概念","BNGO":"Bionano Genomics","BK4121":"生命科学工具和服务"},"translate_title":"简介-Bionano报告第四季度和2023年全年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNGO":0.9},"content_text":"March 5 (Reuters) - Bionano Genomics Inc   :   * BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES REVENUE OUTLOOK FOR 2024   * BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH COMPLETION OF INITIATIVE ANNOUNCED TODAY, WE AIM TO HAVE REDUCED HEADCOUNT BY APPROXIMATELY 200 PEOPLE   * BIONANO GENOMICS INC: REDUCED ANNUALIZED OPERATING EXPENSES BY ABOUT $65.0 TO $75.0 MILLION   * BIONANO GENOMICS INC:  WITH 2024 COST SAVINGS INITIATIVE, WILL BE REDUCING ANNUALIZED OPERATING EXPENSE BY ANOTHER ESTIMATED $35.0 TO $40.0 MILLION   * BIONANO: INITIATIVE INCLUDES POTENTIAL REDUCTION IN HEADCOUNT BY AN ADDITIONAL 110 TO 125 EMPLOYEESSource text for Eikon:    Further company coverage:","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2417420605"}